Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers
- PMID: 11451509
- DOI: 10.1016/s0168-3659(01)00395-9
Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers
Abstract
The goal of this work was to increase the amount of acyclovir (ACV) in the basal epidermis, site of Herpes virus simplex infections, using microparticles as carriers. Poly(D,L-lactic-co-glycolic acid) microparticles loaded with ACV were prepared using a solvent evaporation technique. ACV distribution into porcine skin after topical application of microparticles for 6, 24 and 88 h, was determined by horizontal slicing of the skin. An ACV suspension served for comparison. The results showed that, at 6 and 24 h, the quantity of the drug in the basal epidermis with the microparticles, is similar to that obtained with the ACV suspension. However, after 88 h, the ACV reservoir in the basal epidermis was higher with the microparticles compared with the control suspension. This could be explained by the controlled drug release produced by the vector in the basal epidermis. Besides, at 88 h the amount of ACV detected in the receptor chamber of the diffusion cells was much lower with the microparticles than with the suspension. This type of carrier can improve acyclovir topical therapy since it increases drug retention in the basal epidermis and consequently increases the time intervals between doses.
Similar articles
-
Optimization of topical cidofovir penetration using microparticles.Int J Pharm. 2002 Aug 21;242(1-2):107-13. doi: 10.1016/s0378-5173(02)00178-3. Int J Pharm. 2002. PMID: 12176232
-
PLGA microparticles: possible vehicles for topical drug delivery.Int J Pharm. 2001 Sep 11;226(1-2):181-4. doi: 10.1016/s0378-5173(01)00811-0. Int J Pharm. 2001. PMID: 11532580
-
Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.Pharm Res. 2006 Aug;23(8):1842-9. doi: 10.1007/s11095-006-9017-2. Pharm Res. 2006. PMID: 16850271
-
Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir.J Ocul Pharmacol Ther. 2011 Apr;27(2):163-72. doi: 10.1089/jop.2010.0188. J Ocul Pharmacol Ther. 2011. PMID: 21500985 Free PMC article.
-
Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.Arch Pharm Res. 2010 Apr;33(4):567-74. doi: 10.1007/s12272-010-0411-2. Epub 2010 Apr 27. Arch Pharm Res. 2010. PMID: 20422366
Cited by
-
Enhancement of topical delivery from biodegradable nanoparticles.Pharm Res. 2004 Oct;21(10):1818-25. doi: 10.1023/b:pham.0000045235.86197.ef. Pharm Res. 2004. PMID: 15553228
-
Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.Drug Target Insights. 2007;2:147-57. Epub 2007 Jul 11. Drug Target Insights. 2007. PMID: 21901071 Free PMC article.
-
Microsponges for dermatological applications: Perspectives and challenges.Asian J Pharm Sci. 2020 May;15(3):273-291. doi: 10.1016/j.ajps.2019.05.004. Epub 2019 Jul 9. Asian J Pharm Sci. 2020. PMID: 32636947 Free PMC article. Review.
-
Microparticulate based topical delivery system of clobetasol propionate.AAPS PharmSciTech. 2011 Sep;12(3):949-57. doi: 10.1208/s12249-011-9661-7. Epub 2011 Jul 12. AAPS PharmSciTech. 2011. PMID: 21748539 Free PMC article.
-
Development of microsponges for topical delivery of mupirocin.AAPS PharmSciTech. 2009;10(2):402-9. doi: 10.1208/s12249-009-9220-7. Epub 2009 Apr 21. AAPS PharmSciTech. 2009. PMID: 19381834 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources